Title (en)

NOVEL PLATFORM DNA VACCINE

Title (de)

NEUARTIGE PLATTFORM-DNA-IMPFSTOFF

Title (fr)

NOUVELLE PLATEFORME DE VACCINS À ADN

Publication

EP 3370765 A4 20190612 (EN)

Application

EP 16863078 A 20161104

Priority

• US 201562285732 P 20151106
• US 2016060631 W 20161104

IPC 8 full level

A61K 39/12 (2006.01); A61K 39/145 (2006.01); A61P 33/00 (2006.01); C12N 7/01 (2006.01)

CPC (source: EP)

A61K 39/015 (2013.01); A61P 33/00 (2017.12); A61K 2039/53 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6075 (2013.01); A61K 2039/70 (2013.01); C12N 2760/18534 (2013.01)

Citation (search report)

• [XI] WU H ET AL: "RSV fusion (F) protein DNA vaccine provides partial protection against viral infection", VIRUS RESEARCH, AMSTERDAM, NL, vol. 145, no. 1, 1 October 2009 (2009-10-01), pages 39 - 47, XP026564433, ISSN: 0168-1702, [retrieved on 20090621], DOI: 10.1016/J.VIRUSRES.2009.06.012
• See references of WO 2017079625A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

EP 3370765 A1 20180912; EP 3370765 A4 20190612

DOCDB simple family (application)

EP 16863078 A 20161104